Published April 23, 2021, 7:52 AM Lawmakers have prodded the Department of Health (DOH) to address the reported overpricing of drugs being prescribed to novel coronavirus disease (COVID-19) patients. At the House inquiry Thursday, April 22, on the DOH and the Food and Drug Administration’s (FDA) policies for the registration, distribution and use of the potential COVID-19 drugs, AnaKalusugan Party-List Representative Mike Defensor presented receipts from various individuals showing their hospital expenses for buying medications for their treatment. One receipt showed that a patient in the City of Manila paid P10,852.39 for each dose of anti-viral drug remdesivir, more than triple its original price of P3,055. The patient was made to pay a total of P32,557.17 for three shots.